Skip to main content
  • Home
  •  Transcatheter Interventions Online 2021 – Structural Heart Disease: Live Cases and Discussion

Transcatheter Interventions Online 2021 – Structural Heart Disease: Live Cases and Discussion

Topic:
  • Intervention
  • Structural Heart Disease

Available Credit:

  • 1.00 EBAC

Course Published On:

Course Expiry Date:

TIO 2021 – Structural Heart Disease: Live Cases and Discussion
No ratings

Overview

In this session, part of Transcatheter Interventions Online 2021 – Structural Heart Disease: Live Cases and Discussion, procedures from Erasmus, MC and Brighton and Sussex Hospital demonstrate the latest TAVI treatment and strategies, with further insights provided by an international panel. 
 

Transcatheter Interventions Online (TIO) aims to educate interventionalists and allied healthcare professionals on the practical implications of the latest clinical data, device selection, and procedural strategies impacting optimum patient care. To further illustrate this, the event will feature a number of practical demonstrations in the form of live cases broadcast from cardiovascular centers of excellence globally, interspersed with presentations and debate sessions.

Disclosure

In compliance with EBAC / EACCME guidelines, all speakers/chairpersons participating in this programme have disclosed or indicated potential conflicts of interest which might cause a bias in the presentations.
 

The Organising Committee/Course Director is responsible for ensuring that all potential conflicts of interest relevant to the event are declared to the audience prior to the CME activities.
 

This programme is supported by unrestricted educational grants from the following companies. The scientific programme has not been influenced in any way by the sponsors.
 

  • Edwards Lifesciences

  • Medtronic

  • ABIOMED 

  • Boston Scientific 

Terms & Conditions

Radcliffe Education requires contributors to our CME programmes to disclose any relevant financial relationships that have occurred within the past 12 months that could create a conflict of interest. These will be identified in the faculty section if applicable.
 

The session of ‘Transcatheter Interventions Online 2021 - 'Structural Heart Disease: Live Cases and Discussion’ is accredited by the European Board for Accreditation in Cardiology (EBAC) for 1 hour of external CME credits.
 

Each participant should claim only those hours of credit that have actually been spent in the educational activity. EBAC works according to the quality standards of the European Accreditation Council for Continuing Medical Education (EACCME), which is an institution of the European Union of Medical Specialists (UEMS).
 

Through an agreement between the European Board for Accreditation in Cardiology and the American Medical Association, physicians may convert EBAC External CME credits to AMA PRA Category 1 Credits™. Information on the process to convert EBAC credit to AMA credit can be found on the AMA website.

Target Audience

  • Cardiologists
  • Interventionalists
  • Surgeons who are involved and/or interested in transcatheter treatment strategies for coronary and structural heart disease
  • Interventional cardiology nurses

Learning Objectives

The overall programme, Transcatheter Interventions Online 2021, endeavours to best address the following learning objectives:

  • Discuss the expanding number of indications in TAVI
  • Select appropriate devices for specific patient groups
  • Recall advances in invasive imaging techniques to aid clinical decision making
  • Summarise the essential principles of mechanical circulatory support

Module

Title

Duration

Speakers

Case 1 Live TAVI Case - Rotterdam, Erasmus MC Nicolas M Van Mieghem Joost Daemen
Case 2 Live TAVI Case - Brighton, Brighton and Sussex Hospital David Hildick-Smith
Case 1.

Live TAVI Case - Rotterdam, Erasmus MC

Duration:

Speakers: Nicolas M Van Mieghem Joost Daemen

Case 2.

Live TAVI Case - Brighton, Brighton and Sussex Hospital

Duration:

Speakers: David Hildick-Smith

Chair

Roxana Mehran

Mount Sinai Hospital, New York, NY, US

Roxana Mehran is Professor of Medicine, Cardiology and Professor of Population Health Science and Policy at the Icahn School of Medicine at Mount Sinai in New York.

View full profile

Operator

Nicolas M Van Mieghem

Thoraxcenter, Erasmus University Medical Center, Rotterdam, NL

Prof Nicolas Maria Van Mieghem is an Interventional cardiologist at Thoraxcenter, Erasmus MC, Rotterdam, NL decided to pursue a career that would help others.

View full profile

Operator

David Hildick-Smith

Sussex Cardiac Centre, Brighton and Sussex University Hospitals, Brighton, UK

Prof David Hildick-Smith is Professor of Interventional Cardiology and Consultant Cardiologist at the Sussex Cardiac Centre - the Regional Specialist Unit.

View full profile

Panelist

Lars Søndergaard

Copenhagen University Hospital, Rigshospitalet, Copenhagen, DK

Professor Lars Søndergaard is a consultant cardiologist at Rigshospitalet – Copenhagen, Denmark. Professor of Cardiology at University of Copenhagen, he published over 300 peer reviewed articles, and more than 15 textbook chapters.

View full profile

Panelist

Didier Tchétché

Department of Interventional Cardiology, Clinique Pasteur, Toulouse, France

Didier Tchétché, (Clinique Pasteur, Toulouse, France) Graduated from the University of Paris V where Dr Tchétché obtained his post-graduate diploma of cardiovascular pathology in 2004.

View full profile
1.00 EBAC

Related Courses

TAVI Head-To-Head: Design, Data and Directions for Clinical Practice
  • 1.00 EBAC

Learning objectives

  • Recall TAVI SMART trial data and the implications on clinical practice
  • Describe novel valve designs and the impact on long-term performance
  • Develop an expert-led approach to improving equitable access to TAVI
See more
Getting it Right First Time in Severe Aortic Stenosis - Key Insights for Long Term Success
  • 1.00 EBAC

Learning objectives

  • Recall current and predicted trends in TAVI with respect to preserving coronary access
  • Consider determining factors for choosing valves in low risk populations
  • Discuss solutions for maximising valve durability and haemodynamics and for treating degenerated TAVI
See more
TIO 2023 – Debates
  • 1.00 EBAC

Learning objectives

  • Compare the utility of repair and replacement valve technology in mitral regurgitation
  • Individualise valve choice for aortic regurgitation based on valve durability and patient features
  • Recall the utility and limitations of specialty balloons
  • Evaluate emerging approaches to the treatment of complex left main and other coronary bifurcation lesions
  • Discuss the impact of PCI on top of optimal medical therapy in ischaemic left ventricular systolic dysfunction
  • Identify suitable patients for interatrial shunting
  • Discuss the merits of alternative antiplatelet strategies to DAPT in ACS and CCS following PCI
See more
TIO 2023 – Debates & Controversies – Live Cases & Discussions
  • 1.00 EBAC

Learning objectives

  • Compare the utility of repair and replacement valve technology in mitral regurgitation
  • Individualise valve choice for aortic regurgitation based on valve durability and patient features
  • Recall the utility and limitations of specialty balloons
  • Evaluate emerging approaches to the treatment of complex left main and other coronary bifurcation lesions
  • Discuss the impact of PCI on top of optimal medical therapy in ischaemic left ventricular systolic dysfunction
  • Identify suitable patients for interatrial shunting
See more
TIO 2023 – Keynote & Debate
  • 1.00 EBAC

Learning objectives

  • Compare the utility of repair and replacement valve technology in mitral regurgitation
  • Individualise valve choice for aortic regurgitation based on valve durability and patient features
  • Recall the utility and limitations of specialty balloons
  • Evaluate emerging approaches to the treatment of complex left main and other coronary bifurcation lesions
  • Discuss the impact of PCI on top of optimal medical therapy in ischaemic left ventricular systolic dysfunction
  • Identify suitable patients for interatrial shunting
See more
TIO 2023 – Left Main & Bifurcations – Live Cases & Discussions
  • 1.00 EBAC

Learning objectives

  • Compare the utility of repair and replacement valve technology in mitral regurgitation
  • Individualise valve choice for aortic regurgitation based on valve durability and patient features
  • Recall the utility and limitations of specialty balloons
  • Evaluate emerging approaches to the treatment of complex left main and other coronary bifurcation lesions
  • Discuss the impact of PCI on top of optimal medical therapy in ischaemic left ventricular systolic dysfunction
  • Identify suitable patients for interatrial shunting
  • Discuss the merits of alternative antiplatelet strategies to DAPT in ACS and CCS following PCI
See more
TIO 2023 – Left Main & Bifurcations
  • 1.00 EBAC

Learning objectives

  • Compare the utility of repair and replacement valve technology in mitral regurgitation
  • Individualise valve choice for aortic regurgitation based on valve durability and patient features
  • Recall the utility and limitations of specialty balloons
  • Evaluate emerging approaches to the treatment of complex left main and other coronary bifurcation lesions
  • Discuss the impact of PCI on top of optimal medical therapy in ischaemic left ventricular systolic dysfunction
  • Identify suitable patients for interatrial shunting
  • Discuss the merits of alternative antiplatelet strategies to DAPT in ACS and CCS following PCI
See more
TIO 2023 – Balloon Revolution – Live Cases & Discussions
  • 1.00 EBAC

Learning objectives

  • Compare the utility of repair and replacement valve technology in mitral regurgitation
  • Individualise valve choice for aortic regurgitation based on valve durability and patient features
  • Recall the utility and limitations of specialty balloons
  • Evaluate emerging approaches to the treatment of complex left main and other coronary bifurcation lesions
  • Discuss the impact of PCI on top of optimal medical therapy in ischaemic left ventricular systolic dysfunction
  • Identify suitable patients for interatrial shunting
  • Discuss the merits of alternative antiplatelet strategies to DAPT in ACS and CCS following PCI
See more
TIO 2023 – Balloon Revolution
  • 1.00 EBAC

Learning objectives

  • Compare the utility of repair and replacement valve technology in mitral regurgitation
  • Individualise valve choice for aortic regurgitation based on valve durability and patient features
  • Recall the utility and limitations of specialty balloons
  • Evaluate emerging approaches to the treatment of complex left main and other coronary bifurcation lesions
  • Discuss the impact of PCI on top of optimal medical therapy in ischaemic left ventricular systolic dysfunction
  • Identify suitable patients for interatrial shunting
  • Discuss the merits of alternative antiplatelet strategies to DAPT in ACS and CCS following PCI
See more
TIO 2023 – Key Issues in TAVI - Live Cases and Discussions
  • 1.00 EBAC

Learning objectives

  • Compare the utility of repair and replacement valve technology in mitral regurgitation
  • Individualise valve choice for aortic regurgitation based on valve durability and patient features
  • Recall the utility and limitations of specialty balloons
  • Evaluate emerging approaches to the treatment of complex left main and other coronary bifurcation lesions
  • Discuss the impact of PCI on top of optimal medical therapy in ischaemic left ventricular systolic dysfunction
  • Identify suitable patients for interatrial shunting
  • Discuss the merits of alternative antiplatelet strategies to DAPT in ACS and CCS following PCI
See more